Physician

Alexandria Z Meccia, MD

According to 2025 Medicare claims, Alexandria Meccia, MD (NPI: 1023054954) practices dermatology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1629524632; TIN: 391351587) and primary practice location at 60402-3073.

Meccia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 462 traditional Medicare patients, billed 1,866 HCPCS/CPT codes, and received $90,759 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 949 prescription claims across 340 beneficiaries totaling $271,525 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 22 records totaling $407. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $241,163 to $90,759. In contrast, Part D prescription costs have moved sharply higher in recent years, from $80,525 to $271,525. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$121K$241K2015 Medicare payment: $241,163 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $95,609 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $46,178 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $41,069 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $36,927 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $41,539 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $101,756 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $83,270 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $86,741 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $90,759 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158705,203$241,163
20165002,684$95,609
20172111,089$46,178
20181991,040$41,069
2019187885$36,927
20201931,080$41,539
20213541,766$101,756
20223781,691$83,270
20234321,788$86,741
20244621,866$90,759

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$136K$272K2015 Drug cost: $80,525 (USD; Tot_Drug_Cst)2016 Drug cost: $48,483 (USD; Tot_Drug_Cst)2017 Drug cost: $121,317 (USD; Tot_Drug_Cst)2018 Drug cost: $120,517 (USD; Tot_Drug_Cst)2019 Drug cost: $126,870 (USD; Tot_Drug_Cst)2020 Drug cost: $135,120 (USD; Tot_Drug_Cst)2021 Drug cost: $178,857 (USD; Tot_Drug_Cst)2022 Drug cost: $214,806 (USD; Tot_Drug_Cst)2023 Drug cost: $141,975 (USD; Tot_Drug_Cst)2024 Drug cost: $271,525 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015207429$80,525
2016133278$48,483
201748107$121,317
201864142$120,517
201957124$126,870
2020101257$135,120
2021235701$178,857
2022262693$214,806
2023316766$141,975
2024340949$271,525

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths142165$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more276364$66
11102Biopsy of related skin growth, first growth113124$65
17000Destruction of precancer skin growth, 1 growth149194$41
17003Destruction of precancer skin growth, 2-14 growths99450$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab12322$44,726
MetronidazoleMetronidazole611,992$3,655
TacrolimusTacrolimus32800$3,186
MyrbetriqMirabegron12168$2,766
FluorouracilFluorouracil341,010$2,542

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$407Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandria Z. Meccia, MD?

Tedicare shows public-source Medicare data for Alexandria Z. Meccia, MD (NPI 1023054954), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandria Z. Meccia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandria Z. Meccia, MD?

Alexandria Z. Meccia, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1629524632) in the available physician profile data.

Does Alexandria Z. Meccia, MD have Open Payments data?

Alexandria Z. Meccia, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.